The award for Glasgow University, which was announced by David Willetts, UK Minister of State for Universities and Science, comes from the UK Research Partnership Investment Fund.
The new facilities at the South Glasgow Hospitals Campus will help the fight against diabetes, rheumatology and cardiovascular, respiratory and infectious diseases.
The project is crucial because it seeks to develop so-called "stratified medicine" where treatments are personalised to an individual's genetic make-up and is therefore more effective.
Anna Dominiczak, the university's regius professor of medicine, said: "We are delighted to have secured this funding for the clinical research facility, which will help establish a unique resource for the city and for Scotland.
"Bringing together clinician scientists, NHS clinicians, and industry partners in one place, and providing them with cutting-edge technologies, is key to developing new innovations in medicine."
University principal, professor Anton Muscatelli, added: "This tremendous outcome will have a huge and lasting impact on the development of clinical science and the treatment of chronic diseases."
The research fund supports investment in higher education research facilities to stimulate investment in university research and strengthen the contribution of research to economic growth.